Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CAR.70/IL15-transduced CB-NK cells |
Synonyms | |
Therapy Description |
CAR.70/IL15-transduced CB-NK cells are cord blood-derived natural killer (NK) cells expressing a chimeric antigen receptor (CAR) targeting CD70 and IL15, which potentially induce cytotoxicity in tumor cells expressing CD70 (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CAR.70/IL15-transduced CB-NK cells | CAR.70/IL15-transduced CB-NK cells are cord blood-derived natural killer (NK) cells expressing a chimeric antigen receptor (CAR) targeting CD70 and IL15, which potentially induce cytotoxicity in tumor cells expressing CD70 (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05092451 | Phase Ib/II | CAR.70/IL15-transduced CB-NK cells Cyclophosphamide + Fludarabine | Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances | Recruiting | USA | 0 |
NCT05703854 | Phase Ib/II | CAR.70/IL15-transduced CB-NK cells Cyclophosphamide + Fludarabine | Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma | Recruiting | USA | 0 |